CL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Colgate-Palmolive Co (CL) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite positive analyst ratings and a strong strategic plan, the company's recent financial performance, insider selling trends, and technical indicators suggest caution. Holding the stock or waiting for a better entry point is advisable.
The MACD histogram is negative and contracting, indicating bearish momentum. RSI is at 24.374, suggesting the stock is oversold but not providing a clear buy signal. Moving averages are converging, and the stock is trading near the key support level of 84.485. Overall, the technical indicators do not suggest a strong buy opportunity.
Analysts have raised price targets significantly, with multiple firms maintaining Buy ratings. The company's 2030 Strategic Plan and innovation initiatives are viewed positively. Emerging market exposure and easing comparisons are expected to support growth.
Insiders are selling heavily, with a 20884.53% increase in selling activity over the last month. Recent financial performance shows a significant drop in net income and EPS, raising concerns about profitability. Broader market sentiment is negative, with the S&P 500 down 1.79%. Geopolitical tensions, such as the Strait of Hormuz crisis, could increase market volatility.
In Q4 2025, revenue increased by 5.76% YoY to $5.23 billion. However, net income dropped by 105.01% YoY to -$37 million, and EPS fell by 105.56% YoY to -$0.05. Gross margin slightly declined to 60.15%. The financials indicate revenue growth but significant profitability challenges.
Analysts are generally positive, with multiple firms raising price targets to $100-$105 and maintaining Buy ratings. Analysts highlight strong Q4 performance, sequential growth recovery, and a conservative 2026 guidance. However, some firms maintain neutral ratings, citing challenges in emerging market pricing and inflationary pressures.
